Dr Robert Bingay Challinor I, MD in Allison Park, PA - Urology

Dr Robert Bingay Challinor I, MD is a Urology physician based in Allison Park, Pennsylvania. Dr Robert Bingay Challinor I is licensed to practice in Pennsylvania (license number MD022501L) and his current practice location is 4218 Corton Ct, Allison Park, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (412) 487-3930.

NPI number for Dr Robert Bingay Challinor I is 1811235799 and his current mailing address is 4218 Corton Court, Allison Park, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1811235799.

Contact Information

	Dr Robert Bingay Challinor I, MD
	4218 Corton Ct, Allison Park, PA 15101-2877
	(412) 487-3930
	Not Available

Physician's Profile

Full Name	Dr Robert Bingay Challinor I
Gender	Male
Speciality	Urology
Location	4218 Corton Ct, Allison Park, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1811235799
Provider Enumeration Date: 01/28/2013
Last Update Date: 03/30/2024

Medical Identifiers

Medical identifiers for Dr Robert Bingay Challinor I such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811235799	NPI	-	NPPES
MD022501L	Other	PA	PENNSYLVANIA MEDICAL LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	MD022501L (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Robert Bingay Challinor I is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Robert Bingay Challinor I, MD 4218 Corton Court, Allison Park, PA 15101 Ph: (412) 487-3930	Dr Robert Bingay Challinor I, MD 4218 Corton Ct, Allison Park, PA 15101-2877 Ph: (412) 487-3930

News Archive

Pregnancy can cause metabolic syndrome

Childbearing is associated directly with future development of the metabolic syndrome - abdominal obesity, high triglycerides, insulin resistance and other cardiovascular disease risk factors - and for women who have had gestational diabetes, the risk is more than twice greater, according to a study co-authored by University of Alabama at Birmingham (UAB) researchers published in the American Journal of Obstetrics and Gynecology.

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.

Study explores the effects of COVID-19 on Black and Latino individuals living with HIV

With the COVID-19 pandemic taking a disproportionate toll on low-income people of color, a research team headed by Marya Gwadz of the Silver School of Social Work at New York University set out to understand the ways the pandemic may put individuals at risk for adverse outcomes, and the ways they successfully adapted to and coped with the emerging pandemic, focused on those from low-socioeconomic status backgrounds who have lived with HIV for a decade or longer.

Dr Robert Bingay Challinor I, MD - Urology in Allison Park, PA